Trang chủ

Tài liệu nghiên cứu Y học

Search Journal

Search Article

Search by Auth

Category

From

To

Current Hematologic Malignancy Reports

Volume 14, Issue 1

February 2019( Page 1-62)

Next vol/issue

1. Immunotherapeutic Approaches for Multiple Myeloma: Where Are We Now?

Tác giả

Myo Htut.

2. The Emerging Role of Liquid Biopsies in Lymphoproliferative Disorders

Tác giả

Jennifer Crombie; Philippe Armand.

3. Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective?

Tác giả

Bronwen E. Shaw.

4. Should Overall Survival Remain an Endpoint for Multiple Myeloma Trials?

Tác giả

Sarah A. Holstein; Vera J. Suman.

5. Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?

Tác giả

Shalin Kothari; Jens Hillengass.

6. Industry’s Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy

Tác giả

Stacie Ittershagen; Solveig Ericson.

7. Treatment-Free Remission in CML: the US Perspective

Tác giả

Guru Subramanian Guru Murthy; Ehab Atallah.

8. Correction to: Strategies for Predicting Response to Checkpoint Inhibitors

Tác giả

Roberta Zappasodi;Jedd D. Wolchok;Taha Merghoub.